Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DT01 |
Trade Name | |
Synonyms | |
Drug Descriptions |
DT01 consists of nanoparticles containing short interfering DNA that mimics DNA double strand breaks that are linked to cholesterol, resulting in activation of the DNA damage response in the liver, and potentially leading to increased sensitivity to chemotherapeutic agents (PMID: 26637369, PMID: 28374075, PMID: 27140316). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C99165 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DT01 | DT01 | 0 | 0 |
DT01 + Fluorouracil + Oxaliplatin | DT01 Fluorouracil Oxaliplatin | 1 | 0 |
DT01 + Radiotherapy | DT01 Radiotherapy | 0 | 0 |